Next, the team evaluated how accurately each dog could pick out a disease scent it was trained to detect among other smells.

HopeAI , a Mayo Clinic Platform Accelerate company, is advancing how cancer clinical trials are designed and executed. At the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, HopeAI ...

A new vaccine aimed at a common cancer gene mutation could help stop aggressive pancreatic cancers from coming back, a small ...

UroGen Pharma Ltd. (NASDAQ:URGN) is one of the Stocks With Huge Catalysts on the Horizon. On June 2, UroGen Pharma Ltd. (NASDAQ:URGN) presented its uTRACT Registry study design at the 2025 American ...

Radiation therapy may account for half of all new cancers among the growing population of childhood cancer survivors, according to a study published Aug. 11 in the Journal of Clinical Oncology. With ...

American Cancer Society Cancer Action Network, American Cancer Society, CAMPAIGN, Congress ,funding for cancer research ...

The FDA accepted vepdegestrant’s new drug application for ER+/HER2–, ESR1-mutated advanced breast cancer with a June 5, 2026, ...

More and more providers are beginning to incorporate the new Practical Geriatric Assessment into their practices.

The FDA approved an investigational new drug application for ABT-301, clearing the way for a new clinical trial in metastatic ...

Cervical cancer is highly preventable with routine screening. To provide people with a cervix a comfortable and private ...

American Oncology Network (AON), one of the fastest-growing networks of community-based oncology practices in the United States, today announced the ...